Haoxi Health Technology Limited - Class A Ord Share (HAO)
0.0450
-0.6850 (-93.84%)
NASDAQ · Last Trade: May 11th, 4:50 PM EDT
Detailed Quote
Previous Close
0.7300
Open
0.0635
Bid
0.0432
Ask
0.0434
Day's Range
0.0403 - 0.0664
52 Week Range
0.4500 - 2.310
Volume
228,975,014
Market Cap
-
PE Ratio (TTM)
0.0341
EPS (TTM)
1.3
Dividend & Yield
N/A (N/A)
1 Month Average Volume
49,774
Chart
About Haoxi Health Technology Limited - Class A Ord Share (HAO)
Haoxi Health Technology Limited is a healthcare technology company that focuses on developing innovative solutions and services aimed at enhancing patient care and healthcare delivery. Through its advanced technologies, the company seeks to streamline healthcare processes, improve patient outcomes, and facilitate better communication between healthcare providers and patients. Their portfolio includes software and digital health platforms designed to support various aspects of the healthcare ecosystem, from telemedicine to data analytics, ultimately empowering healthcare professionals and patients alike with accessible and efficient tools. Read More
BEIJING, May 11, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Ltd (NASDAQ: HAO) (“Haoxi” or the “Company”) today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of approximately $6.5 million of the Company’s securities, including 9,000,000 Class A ordinary shares, par value $0.0025 per share (the “Shares”) and 16,999,998 pre-funded warrants, at a purchase price of $0.25 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.0026 per share. Each pre-funded warrant is exercisable to purchase 10.355 Shares.
BEIJING, March 03, 2026 (GLOBE NEWSWIRE) -- HAOXI HEALTH TECHNOLOGY LIMITED (NASDAQ: HAO) (the “Haoxi Health”), a U.S. publicly listed company, and Eaglepoint AI Inc., a subsidiary of Global Mofy AI Limited (NASDAQ: GMM), today jointly announced the signing of a three-year strategic cooperation agreement. The two parties will jointly commit R&D, data, and channel resources to launch an AI health management platform in China. Haoxi Health believes that this partnership marks its's exploration of potential opportunities in the AI-enabled healthcare sector. This collaboration also represents the first time that Eaglepoint AI has deployed its Aquila data engine and multimodal model evaluation system in a high-growth health management scenario.
Gainers Harrison Global Holdings (NASDAQ: BLMZ) stock moved upwards by 20.8% to $0.22 during Friday's pre-market session. The market value of their outstanding shares is at $2.5 million.
BEIJING, April 21, 2025 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, announced that Beijing Haoxi Digital Technology Co., Ltd. (“Haoxi Beijing”), a wholly-owned subsidiary of the Company, has launched its customized livestreaming agency strategy and is progressing partnership discussions on personalized livestreaming agency services with several long-term clients of medical aesthetics, marking a new strategic step in the Company’s business development roadmap.
